(Q61902456)

English

Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant

clinical trial

Statements

Daratumumab for Maintenance in Patients With Relapsed Multiple Myeloma After Salvage Autologous Stem Cell Transplantation (English)
0 references
January 2019
0 references
15 March 2020
0 references
56
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit